cjc/ipamorelin peptide CJC-1295 + Ipamorelin — Therapy Online Blend: Ipamorelin CJC-1295 (No DAC)

Introduced in the 1980s, this synthetic form replaced earlier, less safe methods that involved extracting HGH from human cadavers

Critically, it does not bind the GH receptor in the same way as full-length GH, so it does not elevate IGF-1 or affect glucose homeostasis

Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality

8-week washout: Required after cycles lasting 1216 weeks, and preferred by experienced researchers for full receptor restoration

Unlike older GHRPs, ipamorelin is highly selective, it stimulates growth hormone without significantly raising cortisol or prolactin